Linked Life Data

8882400

Source:http://linkedlifedata.com/resource/pubmed/id/8882400

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1996-12-13
pubmed:abstractText
The objective in the Hungarian randomised double-blind controlled trial was to study the preventive effect of periconceptional multivitamin supplementation on neural tube-defects and other congenital abnormalities. There were 2,471 and 2,391 informative offspring (prenatally diagnosed and terminated malformed fetuses, stillborn fetuses, and liveborn infants) in the multivitamin and placebo-like trace element groups, respectively. A single tablet either of a multivitamin containing 0.8 mg of folic acid or trace element supplement was given daily for at least one month before conception and at least until the date of the second missed menstrual period. The total rate of major congenital abnormalities was 20.6/1,000 in the multivitamin and 40.6/1,000 in the trace element group. After the exclusion of six cases of neural-tube defects in the trace element group the difference was very highly significant [P = 0.0003; relative risk of 0.54 (95% CI 0.39, 0.76)]. Multivitamin supplementation appeared to result in a significant reduction in the rate of urinary tract abnormalities, mainly obstructive defects, and in the rate of sporadic cardiovascular malformations, mainly ventricular septal defects. This report is regarded as a hypothesis-generating study encouraging others to see if the result can be repeated.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0148-7299
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
62
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
179-83
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation.
pubmed:affiliation
Department of Human Genetics and Teratology, National Institute of Hygiene--WHO Collaborating Centre for the Community Control of Hereditary Diseases, Budapest, Hungary.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial